Home > Drugs of dependence: The role of medical professionals.

BMA Science and Education department and the Board of Science.. [BMA] (2013) Drugs of dependence: The role of medical professionals. London: British Medical Association. 341 p.

[img]
Preview
PDF (Drugs of dependence: the role of medical professionals) - Submitted Version
1MB

URL: http://bma.org.uk/news-views-analysis/in-depth-dru...

Executive summary
• Chapter 1 - Introduction
• Chapter 2 - The scale of the problem: illicit drug use in the UK
• Chapter 3 - The burden of illicit drug use
• Chapter 4 - Influences on illicit drug use
• Chapter 5 - Drug policy in the UK: from the 19th century to the present day
• Chapter 6 - Controlling illicit drug use
• Chapter 7 - Delaying initiation and minimising the use of illicit drugs
• Chapter 8 - Medical management of drug dependence: the doctor's role in managing heroin addiction
• Chapter 9 - Medical management of drug dependence: reducing secondary health harms
• Chapter 10 - Medical management of drug dependence in the context of criminal justice: illicit drug use, courts and prison
• Chapter 11 - The role of healthcare professionals

Appendix 1: Membership of the BMA Board of Science Reference Group
Appendix 2: The nature and addictiveness of commonly used illicit drugs
Appendix 3: Health-related harms of emerging and established licit and illicit drugs commonly used in the UK
Appendix 4: UK illicit drug usage data
Appendix 5: Overview of drug adulterants
Appendix 6: UK government strategies for reducing illicit drug use
Appendix 7: Societal measures to restrict drug influences
References

This publication contains a very useful glossary of terms.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder treatment method, AOD prevention, AOD disorder harm reduction, Screening, AOD disorder, AOD disorder drug therapy, Rehabilitation/Recovery, Psychosocial treatment method
Source:BMA
Date:January 2013
Pages:341 p.
Publisher:British Medical Association
Corporate Creators:BMA Science and Education department and the Board of Science.
Place of Publication:London
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Prohibition (Substance use public policy)
J Health care, prevention and rehabilitation > Health care programme or facility > Prison-based health service
HJ Treatment method > Substance disorder treatment method
J Health care, prevention and rehabilitation > Treatment and maintenance > Provider / worker / staff attitude toward treatment
J Health care, prevention and rehabilitation > Health care delivery
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
MA-ML Social science, culture and community > Social costs and benefits > Social costs and benefits of substance use
G Health and disease > State of health
VA Geographic area > Europe > United Kingdom
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
J Health care, prevention and rehabilitation > Substance use prevention
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
A Substance use, abuse, and dependence > Effects and consequences
J Health care, prevention and rehabilitation > Health care programme or facility > Community-based treatment (primary care)
J Health care, prevention and rehabilitation > Basic prevention categories > Targeted prevention
J Health care, prevention and rehabilitation > Basic prevention categories > Universal prevention
N Communication, information and education > Recommendations or guidelines > Practice / clinical guidelines
J Health care, prevention and rehabilitation > Risk and protective factors > Risk factors
T Demographic characteristics > Doctor
G Health and disease > Substance use disorder > Multiple substance use (Polydrug)
HJ Treatment method > Psychosocial treatment method
B Substances > Opioids (opiates)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution) > Methadone maintenance

Repository Staff Only: item control page